Abstract:Резюме Микробиота человека принимает участие в различных физиологических процессах организма, а нарушение ее качественного и количественного состава ассоциировано с развитием ряда заболеваний. Микробиота и макроорганизм сосуществуют в своеобразном симбиозе, где каждый из партнеров извлекает выгоды и оказывает влияние на другого. Эффекты микробиоты проявляются как локально, так и на системном уровне. Функция микробиоты по поддержанию гомеостаза сопоставима с ролью любого другого жизненно важного органа, поэтому… Show more
“…The creation of modern sorbents with desired properties for specific applications is associated not only with the selection of appropriate carriers, but also with the development of a method for their modification and determination of the nature of interactions between biomolecules-carrier surfaces. [20][21][22][23][24][25][26][27][28][29] It is well known that amorphous non-porous fumed silica (Aerosil, Sillard, Polysorb MP silica, nanosilica, colloidal silica, fumed oxides) is an auxiliary substance used in the production of drugs in the form of medical enterosorbents and is characterized by high sorption capacity for proteins and toxins. 19 Highly dispersed fumed oxide silica with a BET surface area S BET in the range of 270-330 m 2 g À1 and low bulk density d b in the range of 20-45 g L À1 was fabricated in the National Academy of Sciences (NAS) of Ukraine in a powder form (A300) and used as an effective medicine with sorption-detoxification properties (e.g., gastrointestinal enteroadsorbents).…”
Section: Introductionmentioning
confidence: 99%
“…The creation of modern sorbents with desired properties for specific applications is associated not only with the selection of appropriate carriers, but also with the development of a method for their modification and determination of the nature of interactions between biomolecules-carrier surfaces. 20–29…”
Entero-vulnerosorbents based on geometrically modified (GM) fumed nanosilica and protein molecules (GM-nanosilica/human serum albumin systems) were characterized with a focus on their surface, morphology, topography, and thermal properties.
“…The creation of modern sorbents with desired properties for specific applications is associated not only with the selection of appropriate carriers, but also with the development of a method for their modification and determination of the nature of interactions between biomolecules-carrier surfaces. [20][21][22][23][24][25][26][27][28][29] It is well known that amorphous non-porous fumed silica (Aerosil, Sillard, Polysorb MP silica, nanosilica, colloidal silica, fumed oxides) is an auxiliary substance used in the production of drugs in the form of medical enterosorbents and is characterized by high sorption capacity for proteins and toxins. 19 Highly dispersed fumed oxide silica with a BET surface area S BET in the range of 270-330 m 2 g À1 and low bulk density d b in the range of 20-45 g L À1 was fabricated in the National Academy of Sciences (NAS) of Ukraine in a powder form (A300) and used as an effective medicine with sorption-detoxification properties (e.g., gastrointestinal enteroadsorbents).…”
Section: Introductionmentioning
confidence: 99%
“…The creation of modern sorbents with desired properties for specific applications is associated not only with the selection of appropriate carriers, but also with the development of a method for their modification and determination of the nature of interactions between biomolecules-carrier surfaces. 20–29…”
Entero-vulnerosorbents based on geometrically modified (GM) fumed nanosilica and protein molecules (GM-nanosilica/human serum albumin systems) were characterized with a focus on their surface, morphology, topography, and thermal properties.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.